Abstract:Twenty one phenylacetylshikonin analogues were synthesized from various substituted phenyl acetic acids and their cytotoxicity values against A549, K562 and L1210 cell lines and antitumor action in mice bearing S-180 cells were measured. All of phenylacetylshikonin analogues expressed a potent cytotoxicity (ED50, 0.1–1.80 μg/ml) against L1210 and K562 cells. L 1210 cells were the most sensitive to shikonin analogues among these cells. Except 4-methoxyphenylacetylshikonin (0.098μg/ml) and α-acetoxyphenylacetylshikonin (0.10μg/ml), all other shikonin derivatives showed higher ED50 values than phenylacetylshikonin (0.13μg/ml) in L 1210. In K562 cell, α-substitution of phenylacetylshikonin (0.1 μg/ml), while other substitutions increased it slightly; 4-methoxyphenylacetylshikonin (0.033 μg/ml) showed a exceptionally good cytotoxicity against K562 cell. 4-Halogenation tended to decrease the cytotoxic effect on L1210 cells, while it enhanced the effect on K562; 4-bromophenylacetyl [ED50 (L1210)=1.76 μ/ml, ED50 (K 562)=0.32 μg/ml] and 4-chlorophenylacetyl shikonin [ED50 (L 1210)=1.64 μg/ml, ED50 (K562)=0.32 μg/ml]. In contrast, A549 cells were much less sensitive to these shikonin analogues which showed ED50 values of 1.5–13.5 μg/ml. Most of phenylacetylshikonin derivatives showed good antitumor activity in mice bearing S-180 cells. α-A-cetoxyphenylacetylshikonin and 4-dimethylaminophenylacetylshikonin showed highest T/C value (192–195%), implying that introduction of α-acetyl or of 4-dimethyl amino group gave a positive effect on the antitumor activity. Introduction of 4-dimethylamino group enhanced the antitumor activity as shown for 4-dimethylaminophenylacetylshikonin (T/C, 192%). It might be due to improvement of water solubility by dimethylamino group in the molecule.

Semi-synthesis and anti-tumor activity of 5,8-O-dimethyl acylshikonin derivatives.

Semi-synthesis and Antitumor Activity of 6-Isomers of 5, 8-O-dimethyl Acylshikonin Derivatives

[Antitumor effect research progress of shikonin and its derivatives]

Design and Synthesis of Fluoroacylshikonin As an Anticancer Agent.

Synthesis and Biological Evaluation of Heterocyclic Carboxylic Acyl Shikonin Derivatives

Synthesis and Antitumor Activity of New Shikonin Glycosides

Design, synthesis and mechanism of novel shikonin derivatives as potent anticancer agents

Design, Synthesis and Biological Evaluation of Cinnamic Acyl Shikonin Derivatives

Antitumor activity of arylacetylshikonin analogues

Synthesis and Antitumour Activity of Β-Hydroxyisovalerylshikonin Analogues.

Synthesis and Evaluation of Novel Alkannin and Shikonin Oxime Derivatives As Potent Antitumor Agents.

Synthesis of Aryl Dihydrothiazol Acyl Shikonin Ester Derivatives As Anticancer Agents Through Microtubule Stabilization.

Synthesis and in Vitro Anticancer Activity of 6,7-Methylenedioxy (or 5-Hydroxy-6-methoxy)-2-(substituted Selenophenyl)Quinolin-4-One Analogs

Synthesis and Biological Evaluation of Novel Shikonin Ester Derivatives As Potential Anti-Cancer Agents

Design, synthesis, and biological evaluation of shikonin and alkannin derivatives as potential anticancer agents via a prodrug approach.

Regioselective semi-synthesis of 6-isomers of 5,8-O-dimethyl ether of shikonin derivatives via an 'intramolecular ring-closing/ring-opening' strategy as potent anticancer agents

Design, Synthesis and Biological Evaluation of Shikonin Thio-Glycoside Derivatives: New Anti-Tubulin Agents

A Partial Synthesis of 5,8-O-dimethylshikonin and 6-Isomer of 5,8-O-dimethylshikonin

Synthesis and biological evaluation of sulfur-containing shikonin oxime derivatives as potential antineoplastic agents

Synthesis and Biological Evaluation of Novel Shikonin-Benzo[b]furan Derivatives As Tubulin Polymerization Inhibitors Targeting the Colchicine Binding Site.

Semi-synthesis and anti-proliferative activity evaluation of novel analogues of Honokiol.